Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Sales and DivestituresNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Molecular Partners Ag (MOLN) Change in Receivables: 2020-2025

Historic Change in Receivables for Molecular Partners Ag (MOLN) over the last 5 years, with Sep 2025 value amounting to $1.6 million.

  • Molecular Partners Ag's Change in Receivables fell 0.34% to $1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$339,979, marking a year-over-year increase of 65.48%. This contributed to the annual value of -$394,435 for FY2024, which is 62.03% up from last year.
  • Molecular Partners Ag's Change in Receivables amounted to $1.6 million in Q3 2025, which was up 203.64% from -$1.5 million recorded in Q2 2025.
  • Molecular Partners Ag's 5-year Change in Receivables high stood at $26.2 million for Q4 2022, and its period low was -$25.3 million during Q4 2021.
  • Moreover, its 3-year median value for Change in Receivables was -$1,834 (2025), whereas its average is -$119,671.
  • Per our database at Business Quant, Molecular Partners Ag's Change in Receivables plummeted by 4,050.10% in 2021 and then soared by 650.40% in 2022.
  • Over the past 5 years, Molecular Partners Ag's Change in Receivables (Quarterly) stood at -$25.3 million in 2021, then soared by 203.36% to $26.2 million in 2022, then tumbled by 104.01% to -$1.1 million in 2023, then skyrocketed by 62.46% to -$394,569 in 2024, then fell by 0.34% to $1.6 million in 2025.
  • Its Change in Receivables stands at $1.6 million for Q3 2025, versus -$1.5 million for Q2 2025 and -$1,834 for Q1 2025.